Stocks / NASDAQ / Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc.

Industry:   Health Care - Biotechnology: Biological Products (No Diagnostic Substances) Stock Symbol:   BCLI - NASDAQ Animal Usage:   Animal Testing

Our Opinion

Brainstorm Cell Therapeutics Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Evidence:

The following article cites that, “The company’s patented NurOwn® technology takes MSCs and, by growing them in proprietary conditions, converts them into biological factories secreting a variety of neurotrophic factors (NTFs). NTFs are growth factors known to support the survival of neurons in a variety of conditions, and in animal models of many neurodegenerative diseases.” Read the full article.

Company Description

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops innovative adult stem cell therapeutic products. It currently focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson’s disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in Hackensack, NJ. [Source: MarketWatch]

Website: http://www.brainstorm-cell.com

Contact:   http://www.brainstorm-cell.com/contact/contact-us; IR: mrice@lifesciadvisors.com;